GlassScriptPhysician profile
Adam S Budzikowski
NPI 1790725125
$259,010.63
in general payments reported to CMS, 2019-2025
44 companies · $20K in 2025
The $20K reported for 2025 was more than what 89% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $29K · 2021: $33K · 2022: $55K · 2023: $28K · 2024: $33K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Food and Beverage: $22K · Travel and Lodging: $14K · Honoraria: $2,800 · Consulting Fee: $1,400 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,300 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,370.00 |
| Food and Beverage | $21,752.26 |
| Travel and Lodging | $13,780.34 |
| Honoraria | $2,800.00 |
| Consulting Fee | $1,400.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,300.00 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $144,355.47 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41,458.47 | 2019-2025 | Lifevest |
| Biotronik INC. | $17,183.75 | 2019-2025 | Solia, Selectra, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $12,532.07 | 2019-2025 | Aveir, Amplatzer Amulet, Gallant |
| Scpharmaceuticals INC. | $11,104.09 | 2024-2025 | |
| Cvrx, INC. | $7,203.73 | 2020-2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $5,274.69 | 2019-2020 | |
| Cardiofocus, INC. | $4,627.40 | 2019-2022 | |
| Boston Scientific Corporation | $3,687.89 | 2019-2025 | Resonate El Icd Vr, General - Tachy, Lux-Dx Insertable Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $2,177.88 | 2022-2025 | Assure Wcd |
| Medtronic, INC. | $1,442.35 | 2021-2025 | Linq II, Cobalt Dr Mri Surescan, Micra |
| Bardy Diagnostics, INC. | $1,237.79 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $996.83 | 2019-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $911.49 | 2023-2025 | Optimizer, Optimizer |
| Sanofi-Aventis U.S. LLC | $533.98 | 2021-2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $489.71 | 2019-2025 | Farxiga, Brilinta, Andexxa |
| Novartis Pharmaceuticals Corporation | $446.14 | 2019-2025 | |
| Abiomed | $377.81 | 2025 | |
| Merck Sharp & Dohme LLC | $333.34 | 2022-2025 | Verquvo, Capvaxive |
| Atricure, INC. | $287.20 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $275.57 | 2020-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $262.85 | 2021-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $255.31 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Shockwave Medical, INC | $221.23 | 2025 | |
| Ebr Systems, INC. | $160.74 | 2025 | |
| Nuwellis, INC. | $146.41 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $124.70 | 2024-2025 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $104.95 | 2019-2021 | |
| Pfizer INC. | $100.50 | 2021-2025 | |
| Medtronic USA, INC. | $94.08 | 2019 | |
| Cordis US Corp. | $78.19 | 2025 | Mynx Control Venous |
| Biosense Webster, INC. | $77.98 | 2024 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Amgen INC. | $75.41 | 2019-2025 | Repatha |
| Lilly USA, LLC | $71.87 | 2020-2024 | Mounjaro, Zepbound |
| Lexicon Pharmaceuticals, INC. | $69.87 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $45.93 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $37.36 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $30.42 | 2022 | |
| Acarix USA INC. | $27.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.20 | 2025 | |
| Philips North America LLC | $18.30 | 2025 | Igt Devices Undivided |
| Astellas Pharma US INC | $14.41 | 2020 | |
| Heartflow, INC. | $14.29 | 2024 | |
| Baxter Healthcare | $13.72 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Budzikowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.